@venkmurthy @chapdoc1 @JJheart_doc Thanks Venk that is the correct link! Please also so the work from @JJheart_doc from PROMISE investigators looking at risk prediction in this group https://t.co/82CxGmNOIf
Study supports the use of high sensitivity troponin I in symptomatic outpatients with possible coronary artery disease as a predictor for cardiovascular events and mortality. Check out the abstract below! #biom4180
Single-Molecule hsTnI and Short-Term Risk in Stable Patients With #ChestPain @JACCJournals
RT @JACCJournals: Do you check hsTroponin in your stable outpatients with chest pain? New #JACC analysis examines this strategy: https://t.…
Abnormal hsTnI increases Short-Term Risk in Stable Patients With Chest Pain https://t.co/t719ykBFoj
RT @krychtiukmd: Can hs-troponin measurement in patients with stable chest pain help in risk stratification and diagnosis? - wonderful ana…
RT @krychtiukmd: Can hs-troponin measurement in patients with stable chest pain help in risk stratification and diagnosis? - wonderful ana…
RT @krychtiukmd: Can hs-troponin measurement in patients with stable chest pain help in risk stratification and diagnosis? - wonderful ana…
RT @krychtiukmd: Can hs-troponin measurement in patients with stable chest pain help in risk stratification and diagnosis? - wonderful ana…
Can hs-troponin measurement in patients with stable chest pain help in risk stratification and diagnosis? - wonderful analysis from PROMISE in @JACCJournals by @JJheart_doc et al. #Cardiology #Cardiotwitter #troponin #atherosclerosis https://t.co/RRp8
RT @JACCJournals: Do you check hsTroponin in your stable outpatients with chest pain? New #JACC analysis examines this strategy: https://t.…
RT @JACCJournals: Do you check hsTroponin in your stable outpatients with chest pain? New #JACC analysis examines this strategy: https://t.…
RT @JACCJournals: Do you check hsTroponin in your stable outpatients with chest pain? New #JACC analysis examines this strategy: https://t.…
@JJheart_doc Towards better understanding in pragmatic cardiology(vis a vis "translational" cardiology- an overused term).
We are all "troponin positive"(a term of reference that needs to go away). Magnitude(of elevation), clinical context, atherosclerotic burden matters. Single-Molecule hsTnI and Short-Term Risk in Stable Patients With Chest Pain https://t.co/aiaGk1cE1D
RT @JACCJournals: Do you check hsTroponin in your stable outpatients with chest pain? New #JACC analysis examines this strategy: https://t.…
RT @JACCJournals: Do you check hsTroponin in your stable outpatients with chest pain? New #JACC analysis examines this strategy: https://t.…
RT @JACCJournals: What is the role of hsTroponin testing in stable outpatients with chest pain? #PROMISE study cohort in #JACC: https://t.c…
RT @JACCJournals: Do you check hsTroponin in your stable outpatients with chest pain? New #JACC analysis examines this strategy: https://t.…
RT @JACCJournals: What is the role of hsTroponin testing in stable outpatients with chest pain? #PROMISE study cohort in #JACC: https://t.c…
RT @DrNitiAggarwal: No surprise: hsTroponins are a marker of outcome in pts with stable #CAD https://t.co/Sr9xyXMnnp
RT @JACCJournals: Do you check hsTroponin in your stable outpatients with chest pain? New #JACC analysis examines this strategy: https://t.…
RT @JACCJournals: Do you check hsTroponin in your stable outpatients with chest pain? New #JACC analysis examines this strategy: https://t.…
RT @JACCJournals: Do you check hsTroponin in your stable outpatients with chest pain? New #JACC analysis examines this strategy: https://t.…
RT @sccccardio: ¿Cuál es el papel de la prueba de hsTroponin en pacientes ambulatorios estables con dolor torácico? #PROMISE cohorte de est…
RT @JACCJournals: Do you check hsTroponin in your stable outpatients with chest pain? New #JACC analysis examines this strategy: https://t.…
RT @JACCJournals: Do you check hsTroponin in your stable outpatients with chest pain? New #JACC analysis examines this strategy: https://t.…
RT @JACCJournals: Do you check hsTroponin in your stable outpatients with chest pain? New #JACC analysis examines this strategy: https://t.…
RT @JACCJournals: Do you check hsTroponin in your stable outpatients with chest pain? New #JACC analysis examines this strategy: https://t.…
RT @JACCJournals: Do you check hsTroponin in your stable outpatients with chest pain? New #JACC analysis examines this strategy: https://t.…
¿Cuál es el papel de la prueba de hsTroponin en pacientes ambulatorios estables con dolor torácico? #PROMISE cohorte de estudio en #JACC: https://t.co/hAFjT4WHsD. @JJheart_doc https://t.co/VVwujLXjFE
RT @JACCJournals: Do you check hsTroponin in your stable outpatients with chest pain? New #JACC analysis examines this strategy: https://t.…
RT @JACCJournals: Do you check hsTroponin in your stable outpatients with chest pain? New #JACC analysis examines this strategy: https://t.…
RT @JACCJournals: Do you check hsTroponin in your stable outpatients with chest pain? New #JACC analysis examines this strategy: https://t.…
RT @JACCJournals: Do you check hsTroponin in your stable outpatients with chest pain? New #JACC analysis examines this strategy: https://t.…
RT @JACCJournals: Do you check hsTroponin in your stable outpatients with chest pain? New #JACC analysis examines this strategy: https://t.…
Do you check hsTroponin in your stable outpatients with chest pain? New #JACC analysis examines this strategy: https://t.co/MSXatvgrM3. @JJheart_doc #cardiotwitter https://t.co/Z9owfyx9ZQ
RT @DrNitiAggarwal: No surprise: hsTroponins are a marker of outcome in pts with stable #CAD https://t.co/Sr9xyXMnnp
RT @DrNitiAggarwal: No surprise: hsTroponins are a marker of outcome in pts with stable #CAD https://t.co/Sr9xyXMnnp
RT @DrNitiAggarwal: No surprise: hsTroponins are a marker of outcome in pts with stable #CAD https://t.co/Sr9xyXMnnp
RT @JACCJournals: What is the role of hsTroponin testing in stable outpatients with chest pain? #PROMISE study cohort in #JACC: https://t.c…
RT @DrNitiAggarwal: No surprise: hsTroponins are a marker of outcome in pts with stable #CAD https://t.co/Sr9xyXMnnp
RT @DrNitiAggarwal: No surprise: hsTroponins are a marker of outcome in pts with stable #CAD https://t.co/Sr9xyXMnnp
RT @DrNitiAggarwal: No surprise: hsTroponins are a marker of outcome in pts with stable #CAD https://t.co/Sr9xyXMnnp
RT @JACCJournals: What is the role of hsTroponin testing in stable outpatients with chest pain? #PROMISE study cohort in #JACC: https://t.c…
RT @JACCJournals: What is the role of hsTroponin testing in stable outpatients with chest pain? #PROMISE study cohort in #JACC: https://t.c…
No surprise: hsTroponins are a marker of outcome in pts with stable #CAD
RT @JACCJournals: What is the role of hsTroponin testing in stable outpatients with chest pain? #PROMISE study cohort in #JACC: https://t.c…
RT @JJheart_doc: Thanks to @JACCJournals for their support. Could hsTn be used to evaluate less acute office based patients with stable ch…
RT @JJheart_doc: Thanks to @JACCJournals for their support. Could hsTn be used to evaluate less acute office based patients with stable ch…
Stable outpatient with chest pain - if his Troponin is > 0.6ng/ml = risk for events..
RT @JACCJournals: What is the role of hsTroponin testing in stable outpatients with chest pain? #PROMISE study cohort in #JACC: https://t.c…
RT @JACCJournals: What is the role of hsTroponin testing in stable outpatients with chest pain? #PROMISE study cohort in #JACC: https://t.c…
RT @JACCJournals: What is the role of hsTroponin testing in stable outpatients with chest pain? #PROMISE study cohort in #JACC: https://t.c…
RT @SABOURETCardio: Your opinion ? @fischman_david @AngoulvantD @jedicath @JosipABorovac @mirvatalasnag @DrMarthaGulati @AnastasiaSMihai @P…
Your opinion ? @fischman_david @AngoulvantD @jedicath @JosipABorovac @mirvatalasnag @DrMarthaGulati @AnastasiaSMihai @PCRonline @rosencher @alxbenevides
RT @JACCJournals: What is the role of hsTroponin testing in stable outpatients with chest pain? #PROMISE study cohort in #JACC: https://t.c…
RT @JJheart_doc: Thanks to @JACCJournals for their support. Could hsTn be used to evaluate less acute office based patients with stable ch…
RT @JJheart_doc: Thanks to @JACCJournals for their support. Could hsTn be used to evaluate less acute office based patients with stable ch…
RT @JJheart_doc: Thanks to @JACCJournals for their support. Could hsTn be used to evaluate less acute office based patients with stable ch…
RT @JJheart_doc: Thanks to @JACCJournals for their support. Could hsTn be used to evaluate less acute office based patients with stable ch…
RT @CardiacCTGuy: Analysis of high-sensitivity troponin in PROMISE trial, low levels of hsTn in patients with stable chest pain predict fut…
RT @JJheart_doc: Thanks to @JACCJournals for their support. Could hsTn be used to evaluate less acute office based patients with stable ch…
RT @JJheart_doc: Thanks to @JACCJournals for their support. Could hsTn be used to evaluate less acute office based patients with stable ch…
RT @JJheart_doc: Thanks to @JACCJournals for their support. Could hsTn be used to evaluate less acute office based patients with stable ch…
RT @JACCJournals: What is the role of hsTroponin testing in stable outpatients with chest pain? #PROMISE study cohort in #JACC: https://t.c…
RT @CardiacCTGuy: Analysis of high-sensitivity troponin in PROMISE trial, low levels of hsTn in patients with stable chest pain predict fut…
JACC Single-Molecule hsTnI and Short-Term Risk in Stable Patients With Chest Pain https://t.co/T2p2mUr3hO https://t.co/Ba6Vvi1SoM
RT @CardiacCTGuy: Analysis of high-sensitivity troponin in PROMISE trial, low levels of hsTn in patients with stable chest pain predict fut…
RT @CardiacCTGuy: Analysis of high-sensitivity troponin in PROMISE trial, low levels of hsTn in patients with stable chest pain predict fut…
Analysis of high-sensitivity troponin in PROMISE trial, low levels of hsTn in patients with stable chest pain predict future MACE. https://t.co/dxWBaYFRo7 Great work lead by @JJheart_doc ! Privilege to work with excellent PROMISE investigators. https://t.